260
Participants
Start Date
November 18, 2021
Primary Completion Date
May 6, 2022
Study Completion Date
May 6, 2022
0.25% Tanfanercept Ophthalmic Solution
Tanfanercept ophthalmic solution.
Placebo
Placebo vehicle solution.
Scott & Christie and Associates, PC, Cranberry Township
Oculus Research, Inc., Garner
Advancing Vision Research, LLC., Smyrna
The Eye Care Institute - Butchertown Clinical Trials, Louisville
Cornea & Cataract Consultants of Arizona, Phoenix
Center For Sight, Henderson
Global Research Management, Glendale
Eye Research Foundation, Inc., Newport Beach
Andover Eye Associates: Raynham, Raynham
Andover Eye Associates: Warwick, Warwick
Lead Sponsor
Collaborators (1)
Daewoong Pharmaceutical Co. LTD.
INDUSTRY
HanAll BioPharma Co., Ltd.
INDUSTRY